BackIdera Pharmaceuticals Overview

Idera Pharmaceuticals Current Cash

Track Idera Pharmaceuticals's current cash ($2.1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.12M
↓ 92.43% YoYΔ $-25.88M vs prior year quarter

Peer average

Loading

Idera Pharmaceuticals Current Cash History

Loading

Idera Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Idera Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Idera Pharmaceuticals (IDRA) FAQ

Idera Pharmaceuticals (IDRA) currently reports a current cash of $2.1M as of March 2023. That compares with $28M in the prior-year period — down 92.4% year over year. Use the charts on this page to explore Idera Pharmaceuticals's current cash history and peer comparisons.

Idera Pharmaceuticals's current cash decreased from $28M to $2.1M — a 92.4% year-over-year decrease (period ending March 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Idera Pharmaceuticals reported $2.1M in current cash as of March 2023. That compares with $28M in the prior-year period — down 92.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $2.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Idera Pharmaceuticals, and consider following IDRA for alerts when major investors trade the stock.

Idera Pharmaceuticals is classified in the Healthcare sector. On current cash, it currently shows $2.1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IDRA with unrelated industries.